Michael B Sporn
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2019First federal award
$950KFederal grants as PI3 awards
3Patents grantedLatest Jun 9, 2026
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $950K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 9, 2020 | NIH | SBIR Phase I Development of the New Synthetic Triterpenoid CDDO-2P-Im for Chemoprevention of the ARDS of COVID-19 | $250K | TRITERPENOID THERAPEUTICS INC |
| Sep 8, 2020 | NIH | SBIR Phase I Development of the New Synthetic Triterpenoid CDDO-2P-IM (TTX01) for Glioblastoma | $400K | TRITERPENOID THERAPEUTICS INC |
| Sep 3, 2019 | NIH | SBIR Phase I Development of the New Synthetic Triterpenoid CDDO-2P-IM (TTX01) for Multiple Myeloma | $300K | TRITERPENOID THERAPEUTICS INC |
4 patents as inventor
- US 12370202TRITERPENOID THERAPEUTICS INCJul 29, 2025
- US 12551562TRITERPENOID THERAPEUTICS INCFeb 17, 2026
- US 12649763TRITERPENOID THERAPEUTICS INCJun 9, 2026
- US TRITERPENOID THERAPEUTICS INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#1,833
Awards as PI#822
Patents#63
Companies
- TRITERPENOID THERAPEUTICS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.